Synthesis of Chiral L2/Z-Type Ligands Featuring a Bisoxazoline Framework and Their Application to Palladium-Catalyzed Asymmetric Allylic Alkylation
Synlett · 18.03.2025 · 36 (05) · 561-565
DOI: 10.1055/a-2377-0844 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synlett, erschienen am 18.03.2025. Verfasst von Ryo Murakami und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Chiral L2/Z*-type ligands featuring a bisoxazoline framework have been successfully synthesized and applied in asymmetric allylic alkylation. These ligands, designed based on an oxazoline skeleton and derived from chiral amino acid derivatives, incorporate antimony and bismuth as Z-type ligands. Ligands with bulky, electron-withdrawing groups on antimony and bismuth showed enhanced catalytic performance. This research highlights the potential of these novel chiral L2/Z*-type ligands to improve asymmetric catalysis.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Murakami, R., Inagaki, F., Takahashi, H., Shibata, T., & Naito, D. (2025). Synthesis of Chiral L2/Z-Type Ligands Featuring a Bisoxazoline Framework and Their Application to Palladium-Catalyzed Asymmetric Allylic Alkylation. Synlett, 36(05), 561-565. https://doi.org/10.1055/a-2377-0844
Vancouver
Murakami R, Inagaki F, Takahashi H, Shibata T, Naito D. Synthesis of Chiral L2/Z-Type Ligands Featuring a Bisoxazoline Framework and Their Application to Palladium-Catalyzed Asymmetric Allylic Alkylation. Synlett. 2025;36(05):561-565. doi:10.1055/a-2377-0844
BibTeX
@article{Murakami2025,
author = {Murakami, Ryo and Inagaki, Fuyuhiko and Takahashi, Hikaru and Shibata, Takashi and Naito, Daisuke},
title = {Synthesis of Chiral L2/Z-Type Ligands Featuring a Bisoxazoline Framework and Their Application to Palladium-Catalyzed Asymmetric Allylic Alkylation},
journal = {Synlett},
year = {2025},
volume = {36},
number = {05},
pages = {561--565},
doi = {10.1055/a-2377-0844}
}
EUVIMED